Mereo BioPharma Group PLC (MREO)
3.26
+0.15
(+4.82%)
USD |
NASDAQ |
May 03, 16:00
3.265
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Net Income (TTM): -29.47M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -29.47M |
| June 30, 2023 | -32.90M |
| December 31, 2022 | -42.22M |
| June 30, 2022 | -22.79M |
| December 31, 2021 | 17.17M |
| June 30, 2021 | -52.87M |
| December 31, 2020 | -223.00M |
| June 30, 2020 | -178.52M |
| Date | Value |
|---|---|
| December 31, 2019 | -45.69M |
| June 30, 2019 | -38.99M |
| December 31, 2018 | -40.64M |
| June 30, 2018 | -45.05M |
| December 31, 2017 | -52.43M |
| June 30, 2017 | -44.96M |
| December 31, 2016 | -35.03M |
| June 30, 2016 | -19.66M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-223.00M
Minimum
Dec 2020
17.17M
Maximum
Dec 2021
-64.93M
Average
-40.61M
Median
Net Income (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -8.826M |
| NuCana PLC | -34.32M |
| TC BioPharm (Holdings) PLC | -7.333M |
| Adaptimmune Therapeutics PLC | -113.87M |
| Autolus Therapeutics PLC | -208.38M |